Novel Investigational Approaches For the Treatment of Neovascular AMD
Dr Paul Hahn and Dr Michael Cohen explore upcoming treatments featuring innovative mechanisms of action and novel delivery systems for addressing neovascular AMD.
Read More
Novel Investigational Approaches for the Treatment of Neovascular AMD
Faricimab Versus High-Dose Aflibercept for the Treatment of Neovascular AMD and DME
Retina specialists evaluate the effectiveness of the two new therapies for neovascular AMD and DME by analyzing their respective clinical trial methodologies and outcomes.
Faricimab versus High-Dose Aflibercept for the Treatment of Neovascular AMD and DME
Achieving Superior Treatment Durability and Outcomes In Neovascular AMD and DME
Expert retina specialists discuss the latest therapies that could reduce the treatment burden and provide superior clinical outcomes in retinal diseases.
Achieving Superior Treatment Durability and Outcomes in Neovascular AMD and DME
